Taboada M - Search Results

1

Metabolic syndrome and asymptomatic peripheral artery disease in subjects over 60 years of age.

Lahoz C, Vicente I, Laguna F, García-Iglesias MF, Taboada M, Mostaza JM. Lahoz C, et al. Among authors: taboada m. Diabetes Care. 2006 Jan;29(1):148-50. doi: 10.2337/diacare.29.1.148. Diabetes Care. 2006. PMID: 16373915 No abstract available.

2

[The application of the SCORE charts to advanced age males triple the number of high-risk subjects compared to the Framingham function].

Mostaza JM, Vicente I, Taboada M, Laguna F, Echániz A, García-Iglesias F, Lahoz C. Mostaza JM, et al. Among authors: taboada m. Med Clin (Barc). 2005 Apr 9;124(13):487-90. doi: 10.1157/13073561. Med Clin (Barc). 2005. PMID: 15847765 Spanish.

3

[Prevalence of an abnormal ankle-brachial index in relation to the cardiovascular risk estimated by the Framingham function].

Vicente I, Lahoz C, Taboada M, García A, San Martín MA, Terol I, Laguna F, García-Iglesias F, Mostaza JM. Vicente I, et al. Among authors: taboada m. Med Clin (Barc). 2005 May 7;124(17):641-4. doi: 10.1157/13074738. Med Clin (Barc). 2005. PMID: 15882509 Spanish.

4

Baseline levels of low-density lipoprotein cholesterol and lipoprotein (a) and the AvaII polymorphism of the low-density lipoprotein receptor gene influence the response of low-density lipoprotein cholesterol to pravastatin treatment.

Lahoz C, Peña R, Mostaza JM, Laguna F, García-Iglesias MF, Taboada M, Pintó X. Lahoz C, et al. Among authors: taboada m. Metabolism. 2005 Jun;54(6):741-7. doi: 10.1016/j.metabol.2004.12.020. Metabolism. 2005. PMID: 15931608 Clinical Trial.

5

The -514C/T polymorphism of the hepatic lipase gene significantly modulates the HDL-cholesterol response to statin treatment.

Lahoz C, Peña R, Mostaza JM, Laguna F, García-Iglesias MF, Taboada M, Pintó X; RAP Study Group. Lahoz C, et al. Among authors: taboada m. Atherosclerosis. 2005 Sep;182(1):129-34. doi: 10.1016/j.atherosclerosis.2005.02.001. Epub 2005 Feb 26. Atherosclerosis. 2005. PMID: 16115483 Clinical Trial.

6

Factors associated with the discontinuation of evidence-based cardiovascular therapies in patients with stable coronary artery disease: a primary care perspective.

Mostaza JM, Lahoz C, Martín-Jadraque R, Sanmartín MA, Vicente I, Tranche S, Taboada M, Mantilla T, Monteiro B, Sanchez-Zamorano MA; PRESENAP study. Mostaza JM, et al. Among authors: taboada m. Eur J Cardiovasc Prev Rehabil. 2009 Feb;16(1):34-8. doi: 10.1097/HJR.0b013e32831a47f3. Eur J Cardiovasc Prev Rehabil. 2009. PMID: 19237995

7

Atherogenic dyslipidemia in patients with established coronary artery disease.

Lahoz C, Mostaza JM, Tranche S, Martin-Jadraque R, Mantilla MT, López-Rodriguez I, Monteiro B, Sanchez-Zamorano MA, Taboada M. Lahoz C, et al. Among authors: taboada m. Nutr Metab Cardiovasc Dis. 2012 Feb;22(2):103-8. doi: 10.1016/j.numecd.2010.04.010. Epub 2010 Aug 2. Nutr Metab Cardiovasc Dis. 2012. PMID: 20675108

8

[Prevalence of metabolic syndrome in patients with stable coronary disease: therapeutic objectives and utilization of cardiovascular drugs].

Lahoz C, Mostaza JM, Mantilla MT, Taboada M, Tranche S, López-Rodríguez I, Monteiro B, Sánchez-Zamorano MA, Martín-Jadraque R. Lahoz C, et al. Among authors: taboada m. Rev Clin Esp. 2011 Jan;211(1):1-8. doi: 10.1016/j.rce.2010.05.018. Epub 2010 Dec 31. Rev Clin Esp. 2011. PMID: 21196002 Spanish.

9

Apo A-I promoter polymorphism influences basal HDL-cholesterol and its response to pravastatin therapy.

Lahoz C, Peña R, Mostaza JM, Jiménez J, Subirats E, Pintó X, Taboada M, López-Pastor A; RAP Study Group. Lahoz C, et al. Among authors: taboada m. Atherosclerosis. 2003 Jun;168(2):289-95. doi: 10.1016/s0021-9150(03)00094-7. Atherosclerosis. 2003. PMID: 12801612

10

Achievement of therapeutic goals and utilization of evidence-based cardiovascular therapies in coronary heart disease patients with chronic kidney disease.

Lahoz C, Mostaza JM, Mantilla MT, Taboada M, Tranche S, López-Rodriguez I, Monteiro B, Soler B, Sanchez-Zamorano MA, Martin-Jadraque R. Lahoz C, et al. Among authors: taboada m. Am J Cardiol. 2008 Apr 15;101(8):1098-102. doi: 10.1016/j.amjcard.2007.12.009. Epub 2008 Feb 7. Am J Cardiol. 2008. PMID: 18394440

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

203 results

Search Page

Filters